Optimal synthetic glycosylation of a therapeutic antibody
Glycosylation patterns in antibodies critically determine biological and physical properties but their precise control is a significant challenge in biology and biotechnology. We describe herein the optimization of an endoglycosidase-catalyzed glycosylation of the best-selling biotherapeutic Hercept...
Main Authors: | Parsons, T, Struwe, W, Gault, J, Yamamoto, K, Taylor, T, Raj, R, Wals, K, Mohammed, S, Robinson, C, Benesch, J, Davis, B |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wiley
2016
|
Similar Items
-
Controlled glycosylation of therapeutic antibodies in plants.
by: Tekoah, Y, et al.
Published: (2004) -
Directed Evolution of Therapeutic Antibodies Targeting Glycosylation in Cancer
by: Ron Amon, et al.
Published: (2020-09-01) -
Glycosylation engineering of therapeutic IgG antibodies: challenges for the safety, functionality and efficacy
by: Yusuke Mimura, et al.
Published: (2017-06-01) -
Roles of quaternary architectures in immunoglobulin glycosylation and antibody-based therapeutics
by: Le, N
Published: (2018) -
Site-selective glycosylation of proteins: creating synthetic glycoproteins.
by: van Kasteren, S, et al.
Published: (2007)